Bailard, Inc. Teva Pharmaceutical Industries LTD Transaction History

Bailard, Inc.

$3.84 Billion
Q4 2024

A detailed history of Bailard, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Bailard, Inc. holds 310,000 shares of TEVA stock, worth $5.14 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

310,000

Holding current value

$5.14 Million

% of portfolio

0.18%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$16.43 - $22.77 $5.09 Million - $7.06 Million	310,000 New	310,000 $6.83 Million
Q3 2020 Nov 10, 2020	SELL	$8.57 - $12.69 $2.85 Million - $4.21 Million	-332,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$8.12 - $13.12 $2.7 Million - $4.36 Million	332,000 New	332,000 $4.09 Million
Q2 2019 Jul 26, 2019	SELL	$8.12 - $15.72 $2.93 Million - $5.67 Million	-360,495 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$15.58 - $20.01 $560,957 - $720,460	-36,005 Reduced 9.08%	360,495 $5.65 Million
Q4 2018 Feb 05, 2019	BUY	$14.59 - $23.84 $391,012 - $638,912	26,800 Added 7.25%	396,500 $6.11 Million
Q3 2018 Nov 13, 2018	BUY	$21.06 - $25.65 $6.09 Million - $7.42 Million	289,339 Added 360.05%	369,700 $7.96 Million
Q3 2016 Jan 29, 2018	SELL	N/A	-80,045 Reduced 49.9%	80,361 $3.7 Million
Q2 2016 Jan 29, 2018	SELL	N/A	-54,894 Reduced 25.5%	160,406 $0
Q1 2016 Jan 29, 2018	BUY	N/A	65,300 Added 43.53%	215,300 $11.5 Million
Q4 2015 Jan 29, 2018	SELL	N/A	-65,300 Reduced 30.33%	150,000 $0
Q3 2015 Jan 29, 2018	SELL	N/A	-35,000 Reduced 13.98%	215,300 $12.2 Million
Q4 2014 Jan 29, 2018	BUY	N/A	250,300	250,300 $0

Others Institutions Holding TEVA

# of Institutions

647

Shares Held

585M

Call Options Held

18.8M

Put Options Held

7.13M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.

Account